Latest period
$61.3M
YoY change
+34.1%
5Y CAGR
-18.1%
Peak year (FY2020)
$82.2M
Latest annual
$30.3M
Cash on Hand history chart for Equillium (EQ) from 2017 to 2025
Latest: $30.3M
Cash on Hand growth chart for Equillium (EQ) from 2017 to 2025
Latest: +34.1%
Cash on Hand history table for Equillium (EQ) from 2017 to 2025
| FY2025 | $30.3M | +34.1% | +$7.7M | ||
| FY2024 | $22.6M | -44.8% | -$18.3M | ||
| FY2023 | $40.9M | -42.5% | -$30.2M | ||
| FY2022 | $71M | -12.0% | -$9.69M | ||
| FY2021 | $80.7M | -1.8% | -$1.45M | ||
| FY2020 | $82.2M | +54.6% | +$29M | ||
| FY2019 | $53.1M | -19.4% | -$12.8M | ||
| FY2018 | $65.9M | +827.9% | +$58.8M | ||
| FY2017 | $7.1M | — | — |
- FY2025$30.3M+34.1%
- FY2024$22.6M-44.8%
- FY2023$40.9M-42.5%
- FY2022$71M-12.0%
- FY2021$80.7M-1.8%
- FY2020$82.2M+54.6%
- FY2019$53.1M-19.4%
- FY2018$65.9M+827.9%
- FY2017$7.1M—
Cash on Hand values are taken from Equillium's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Equillium (EQ)
According to Equillium's latest reported financial statements, the company's latest reported cash and short-term investments is $61.3M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Equillium (EQ) cash and short-term investments is $30.3M – surged 34.1% year-over-year.
Equillium cash and short-term investments has contracted on net over the period, with a -18.1% compound annual growth rate over 2020–2025 (5 years).
Equillium cash and short-term investments peaked at $82.2M in 2020; the latest annual figure is $30.3M in 2025 (63.2% below peak).
Across the available history, cash and short-term investments reached its high of $82.2M in 2020 and its low of $7.1M in 2017.
Equillium Cash on Hand by Year
Equillium Cash on Hand 2025: $30.3M
In 2025, Equillium reported cash and short-term investments of $30.3M, surged 34.1% from 2024.
Equillium Cash on Hand 2024: $22.6M
Equillium cash and short-term investments in 2024 was $22.6M, plunged 44.8% below 2023.
Equillium Cash on Hand 2023: $40.9M
2023's cash and short-term investments for Equillium came in at $40.9M, plunged 42.5% below 2022.
Equillium Cash on Hand 2022: $71M
Equillium posted cash and short-term investments of $71M in 2022, declined 12.0% below 2021.
Equillium Cash on Hand 2021: $80.7M
Equillium cash and short-term investments in 2021 was $80.7M.
See more financial history for Equillium (EQ).
Sector peers by Cash on Hand
Healthcare peers of Equillium (EQ), ranked by their latest cash and short-term investments
| $28.1B | |
| $20.1B | |
| $14.6B | |
| $10.1B | |
| $9.13B | |
| $7.27B | |
| $5.26B | |
| $4.24B |
- $28.1B
- $20.1B
- $14.6B
- $9.13B
- $7.27B
- $5.26B
- $4.24B
Frequently asked questions
Equillium (EQ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.